Skip to content. | Skip to navigation

You are here: Home / Case database / Transparency International Germany vs. Ratiopharm

Transparency International Germany vs. Ratiopharm

Case overview

Date filed 20 April 2006
Current status Rejected
Issue Ratiopharm's unethical marketing in Germany, Belgium et al
Summary of the case Ratiopharm, a pharmaceuticals company and major producer of generic drugs, has allegedly engaged in unethical marketing practices, including bribing doctors and pharmacists in Belgium, Canada, Spain, Estonia and Germany.

Developments/Outcome In June 2006, the German NCP rejected the complaint citing the lack of transnational investment. Specifically, the NCP stated the complaint only dealt with alleged misbehaviour in Germany. In July 2006, Transparency International Germany resubmitted a revised and expanded complaint
Relevant OECD Guidelines
Case keywords Supply chain, Anti-competitive practices, Investment nexus, Disclosure of information, Bribery / Corruption, Multiple NCPs

NCP Information

NCP name National Contact Point Germany
NCP address Scharnhorststrasse 34-37 D-10115 Berlin, Germany
NCP website www.bmwi.de/go/nationale-kontaktstelle
Other NCPs involved

Complainant

NGO

Company Information

Company responsible Ratiopharm
Company address Graf-Arco-Strasse 3 3
Ulrum
Netherlands
Company website http://www2.ratiopharm.com/de/de/pub/home.cfm
Company in violation Ratiopharm
Country of operations Germany
Other companies involved

Timeline of developments

Some developments are only visible to logged in users.
Date Actor Action Description Document
18 July 2006 Transparency International - Germany file TI submits revised and expanded complaint (see: Transparency International - Germany vs. Ratiopharm refile).  
20 April 2006 Transparency International - Germany file Complaint submitted to German NCP.  

Personal tools

OECD Watch is hosted by